Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
+$1.75B |
| 2 |
NVIDIA
NVDA
|
+$1.34B |
| 3 |
Capital One
COF
|
+$1.16B |
| 4 |
Apple
AAPL
|
+$1.01B |
| 5 |
Amazon
AMZN
|
+$813M |
Top Sells
| 1 |
DFS
Discover Financial Services
DFS
|
+$1.09B |
| 2 |
Palantir
PLTR
|
+$777M |
| 3 |
Coca-Cola
KO
|
+$496M |
| 4 |
Qualcomm
QCOM
|
+$469M |
| 5 |
Applovin
APP
|
+$390M |
Sector Composition
| 1 | Technology | 32.48% |
| 2 | Financials | 14.03% |
| 3 | Consumer Discretionary | 10.52% |
| 4 | Healthcare | 9.35% |
| 5 | Communication Services | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3801
Live Ventures
LIVE
$53.4M
| $248K | ﹤0.01% |
14,285
-2,270
| -14% | -$39.5K |
|
3802
Capital Southwest
CSWC
$1.27B
| $248K | ﹤0.01% |
11,251
| – | – |
|
3803
Telomir Pharmaceuticals
TELO
$46M
| $246K | ﹤0.01% |
196,880
-232,372
| -54% | -$291K |
|
3804
Comscore
SCOR
$31.7M
| $246K | ﹤0.01% |
51,057
-432
| -0.8% | -$2.08K |
|
3805
ABVC BioPharma
ABVC
$64.7M
| $246K | ﹤0.01% |
110,499
+6,017
| +6% | +$13.4K |
|
3806
Aligos Therapeutics
ALGS
$78M
| $246K | ﹤0.01% |
34,048
+5,978
| +21% | +$43.1K |
|
3807
Drilling Tools International
DTI
$69.5M
| $244K | ﹤0.01% |
85,694
-134,054
| -61% | -$382K |
|
3808
Vicarious Surgical
RBOT
$36.8M
| $243K | ﹤0.01% |
32,434
+631
| +2% | +$4.73K |
|
3809
Femasys
FEMY
$12.2M
| $243K | ﹤0.01% |
251,394
+5,887
| +2% | +$5.69K |
|
3810
Glimpse Group
VRAR
$29.9M
| $242K | ﹤0.01% |
177,945
+2,268
| +1% | +$3.09K |
|
3811
Gray Media, Inc. Class A
GTN.A
$1.02B
| $242K | ﹤0.01% |
22,227
+2,086
| +10% | +$22.7K |
|
3812
NeueHealth
NEUE
$60.9M
| $241K | ﹤0.01% |
34,960
+24
| +0.1% | +$166 |
|
|
ARTV
3813
Artiva Biotherapeutics, Inc. Common Stock
ARTV
$67.9M
| $240K | ﹤0.01% |
159,041
-251,416
| -61% | -$380K |
|
3814
Woori Financial
WF
$13.2B
| $240K | ﹤0.01% |
+4,829
| New | +$240K |
|
3815
DarioHealth
DRIO
$21.9M
| $240K | ﹤0.01% |
17,917
-282
| -2% | -$3.78K |
|
|
RYM
3816
RYTHM, Inc. Common Stock
RYM
$78.9M
| $239K | ﹤0.01% |
11,708
+289
| +3% | +$5.91K |
|
|
IGMS
3817
DELISTED
IGM Biosciences
IGMS
| $239K | ﹤0.01% |
213,273
-212,387
| -50% | -$238K |
|
3818
Oxbridge Re Holdings
OXBR
$17.1M
| $238K | ﹤0.01% |
136,984
+1,568
| +1% | +$2.73K |
|
3819
Cryo-Cell International
CCEL
$36.2M
| $238K | ﹤0.01% |
45,831
+601
| +1% | +$3.12K |
|
3820
Innoviz Technologies
INVZ
$375M
| $237K | ﹤0.01% |
144,534
+71,334
| +97% | +$117K |
|
3821
NeuroOne Medical Technologies
NMTC
$44.7M
| $237K | ﹤0.01% |
348,825
+2,849
| +0.8% | +$1.93K |
|
3822
Tempest Therapeutics
TPST
$48.8M
| $236K | ﹤0.01% |
34,736
+1,402
| +4% | +$9.53K |
|
3823
FibroGen
FGEN
$46.4M
| $233K | ﹤0.01% |
44,036
+856
| +2% | +$4.54K |
|
3824
Coffee Holding Co
JVA
$23.3M
| $232K | ﹤0.01% |
53,581
-695
| -1% | -$3.01K |
|
|
CHA
3825
Chagee Holdings Limited American Depositary Shares
CHA
$3.15B
| $232K | ﹤0.01% |
+8,882
| New | +$232K |
|